Gwendolyn Binder-Scholl
Direttore Tecnico/Scientifico/R&S presso CABALETTA BIO, INC.
Patrimonio netto: 203 800 $ in data 31/05/2024
Posizioni attive di Gwendolyn Binder-Scholl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CABALETTA BIO, INC. | Direttore Tecnico/Scientifico/R&S | 01/02/2019 | - |
| INSTIL BIO, INC. | Direttore/Membro del Consiglio | 01/07/2020 | - |
| Independent Dir/Board Member | 01/07/2020 | - |
Storia della carriera di Gwendolyn Binder-Scholl
Precedenti posizioni note di Gwendolyn Binder-Scholl
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Direttore Tecnico/Scientifico/R&S | 01/02/2016 | 31/01/2019 |
| Corporate Officer/Principal | 01/03/2011 | 01/02/2016 | |
| University of Pennsylvania | Corporate Officer/Principal | 01/01/2006 | 01/01/2011 |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2002 | 01/01/2005 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Corporate Officer/Principal | - | - |
Formazione di Gwendolyn Binder-Scholl
| The Johns Hopkins University | Doctorate Degree |
| Wells College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CABALETTA BIO, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Health Services |
